Mayo Clinic has chosen its Florida CEO, Dr. Gianrico Farrugia, to succeed Dr. John Noseworthy as the health system’s next top leader. Farrugia is a physician and researcher who has sought to bring genomics into routine clinical care.
ACOs would have to attest every year that a certain percentage of their eligible clinicians are using EHRs that meet 2015 edition requirements, a move that would more closely align requirements with those of the Quality Payment Program.
Intermountain Healthcare has added two new executives to its leadership team, replacing a former chief people officer and naming a new chief strategy officer.
The CMS’ move to allow Medicare Advantage plans to require patients to try low-cost generic drugs before more expensive therapies on Part B could lead to poor health outcomes, causing an increase in ED use and inpatient admissions, providers say.
More than 400 “Dear Doctor” letters, sent last year in San Diego County, were part of a study that, researchers say, put a human face on the U.S. opioid crisis for many doctors.
HHS Secretary Alex Azar hinted the agency will overhaul certificate-of-need regulations and force drugmakers to pay full rebates to state Medicaid programs for new formulations of existing drugs.
The North Carolina Department of Health and Human Services will award four statewide Medicaid managed care contracts and up to 12 regional contracts worth a total $6 billion per year.